2seventy Bio Stock Fundamentals
| TSVT Stock | USD 3.99 0.03 0.76% |
2Seventy Bio fundamentals help investors to digest information that contributes to 2Seventy Bio's financial success or failures. It also enables traders to predict the movement of 2Seventy Stock. The fundamental analysis module provides a way to measure 2Seventy Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 2Seventy Bio stock.
At this time, 2Seventy Bio's Net Interest Income is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 10.7 M in 2024, whereas Operating Income is likely to drop (227.5 M) in 2024. 2Seventy | Select Account or Indicator |
2Seventy Bio Company Return On Equity Analysis
2Seventy Bio's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current 2Seventy Bio Return On Equity | -0.52 |
Most of 2Seventy Bio's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 2Seventy Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
2Seventy Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, 2Seventy Bio has a Return On Equity of -0.5189. This is 97.84% lower than that of the Biotechnology sector and 98.58% lower than that of the Health Care industry. The return on equity for all United States stocks is 67.39% higher than that of the company.
2Seventy Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 2Seventy Bio's current stock value. Our valuation model uses many indicators to compare 2Seventy Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 2Seventy Bio competition to find correlations between indicators driving 2Seventy Bio's intrinsic value. More Info.2Seventy Bio is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, 2Seventy Bio's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value 2Seventy Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.2Seventy Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 2Seventy Bio's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 2Seventy Bio could also be used in its relative valuation, which is a method of valuing 2Seventy Bio by comparing valuation metrics of similar companies.2Seventy Bio is currently under evaluation in return on equity category among its peers.
2Seventy Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, 2Seventy Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to 2Seventy Bio's managers, analysts, and investors.Environmental | Governance | Social |
2Seventy Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (2.07) % | ||||
| Operating Margin | (0.99) % | ||||
| Current Valuation | 259.34 M | ||||
| Shares Outstanding | 51.59 M | ||||
| Shares Owned By Insiders | 4.05 % | ||||
| Shares Owned By Institutions | 90.88 % | ||||
| Number Of Shares Shorted | 5.1 M | ||||
| Price To Book | 0.90 X | ||||
| Price To Sales | 4.48 X | ||||
| Revenue | 100.39 M | ||||
| Gross Profit | (183.46 M) | ||||
| EBITDA | (206.42 M) | ||||
| Net Income | (217.57 M) | ||||
| Cash And Equivalents | 357.93 M | ||||
| Cash Per Share | 9.45 X | ||||
| Total Debt | 256.67 M | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 3.88 X | ||||
| Book Value Per Share | 4.56 X | ||||
| Cash Flow From Operations | (166.86 M) | ||||
| Short Ratio | 16.53 X | ||||
| Earnings Per Share | (1.83) X | ||||
| Target Price | 8.25 | ||||
| Number Of Employees | 274 | ||||
| Beta | 1.79 | ||||
| Market Capitalization | 204.29 M | ||||
| Total Asset | 565.43 M | ||||
| Retained Earnings | (511.22 M) | ||||
| Working Capital | 177.99 M | ||||
| Net Asset | 565.43 M |
About 2Seventy Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 2Seventy Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 2Seventy Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 2Seventy Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 15.4 M | 16.2 M | |
| Total Revenue | 100.4 M | 108.8 M | |
| Cost Of Revenue | 16.9 M | 10.1 M | |
| Stock Based Compensation To Revenue | 0.32 | 0.30 | |
| Research And Ddevelopement To Revenue | 2.30 | 3.93 | |
| Capex To Revenue | 0.14 | 0.13 | |
| Revenue Per Share | 2.04 | 4.00 | |
| Ebit Per Revenue | (2.16) | (2.27) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for 2Seventy Stock Analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.